Bank of America’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.08M Buy
165,125
+71,838
+77% +$1.34M ﹤0.01% 3681
2025
Q1
$1.69M Buy
93,287
+15,114
+19% +$274K ﹤0.01% 4029
2024
Q4
$1.7M Sell
78,173
-9,858
-11% -$215K ﹤0.01% 3874
2024
Q3
$2.41M Buy
88,031
+69,657
+379% +$1.91M ﹤0.01% 3743
2024
Q2
$476K Buy
18,374
+2,879
+19% +$74.5K ﹤0.01% 4613
2024
Q1
$465K Buy
15,495
+11,366
+275% +$341K ﹤0.01% 4594
2023
Q4
$42.9K Buy
4,129
+4,007
+3,284% +$41.7K ﹤0.01% 5710
2023
Q3
$1.67K Sell
122
-1,623
-93% -$22.2K ﹤0.01% 6246
2023
Q2
$21.2K Sell
1,745
-19
-1% -$230 ﹤0.01% 5818
2023
Q1
$22.4K Buy
1,764
+1,324
+301% +$16.8K ﹤0.01% 5920
2022
Q4
$2.78K Buy
440
+429
+3,900% +$2.71K ﹤0.01% 6348
2022
Q3
$0 Buy
11
+9
+450% ﹤0.01% 6980
2022
Q2
$0 Sell
2
-503
-100% ﹤0.01% 7195
2022
Q1
$23K Sell
505
-2,598
-84% -$118K ﹤0.01% 6668
2021
Q4
$220K Buy
3,103
+689
+29% +$48.9K ﹤0.01% 5645
2021
Q3
$281K Buy
2,414
+1,696
+236% +$197K ﹤0.01% 5233
2021
Q2
$113K Sell
718
-6,071
-89% -$955K ﹤0.01% 5666
2021
Q1
$1.29M Buy
6,789
+5,744
+550% +$1.09M ﹤0.01% 4064
2020
Q4
$131K Sell
1,045
-1,714
-62% -$215K ﹤0.01% 5116
2020
Q3
$300K Buy
2,759
+1,663
+152% +$181K ﹤0.01% 4467
2020
Q2
$132K Sell
1,096
-322
-23% -$38.8K ﹤0.01% 4969
2020
Q1
$142K Buy
1,418
+555
+64% +$55.6K ﹤0.01% 4735
2019
Q4
$209K Sell
863
-134
-13% -$32.5K ﹤0.01% 4829
2019
Q3
$163K Buy
997
+142
+17% +$23.2K ﹤0.01% 4992
2019
Q2
$201K Buy
855
+112
+15% +$26.3K ﹤0.01% 4885
2019
Q1
$196K Buy
743
+187
+34% +$49.3K ﹤0.01% 4811
2018
Q4
$51K Buy
556
+504
+969% +$46.2K ﹤0.01% 5454
2018
Q3
$10K Buy
+52
New +$10K ﹤0.01% 5922